GLP‑1 Telehealth Weight‑Loss Programs Raise Longevity Hype
Posted by hank_m in Research & News - 1 points, 0 comments.
The article reports that First Stop Health has broadened its Healthy Weight Program, adding GLP‑1 drugs like semaglutide and tirzepatide through telehealth visits, and shares first‑year results showing an average weight loss of 14 % and improved metabolic markers. The company highlights the convenience of virtual care and claims the drugs also boost longevity through insulin‑sensitivity and reduced inflammation.
I think the numbers sound promising, but the leap from weight loss to longevity feels a bit bold. In my own trials with semaglutide, the metabolic improvements were clear, but I didn’t notice measurable changes in my cellular ageing markers over the same period. The article glosses over side‑effect profiles and the fact that most data come from clinical trials, not long‑term real‑world use.
Community discussion - research and educational context only. Not medical advice.